Pfizer

U.S. decision on Pfizer COVID-19 shot for kids age 5-11 could come in October -sources

Sept 10 (Reuters) - Top U.S. health officials believe that Pfizer Inc's COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources…

Read More Here

U.S. COVID-19 booster shot campaign to start with only Pfizer – source

WASHINGTON, Sept 3 (Reuters) - A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech…

Read More Here

UPDATED: New Zealand reports first death linked to Pfizer COVID-19 vaccine

New Zealand reported its first recorded death linked to U.S. drugmaker Pfizer's COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare side effect leading to…

Read More Here

Pfizer vaccine safe in small study of very sick kids

In adolescents with serious neurological conditions, the side effects of the Pfizer/BioNTech vaccine are likely to be mild to moderate and clear up quickly, a small study suggests. The 27…

Read More Here

Third Pfizer dose 86% effective in over 60s, Israeli HMO says

A third dose of Pfizer /BioNTech's COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from…

Read More Here

Pfizer, BioNtech submit data to FDA for COVID-19 vaccine booster authorization

(Reuters) - Pfizer Inc and German partner BioNtech SE have submitted initial data from an early stage trial to support application seeking authorization of a booster dose of their COVID-19…

Read More Here

Pfizer expands recall of anti-smoking drug Chantix over carcinogen presence

Pfizer Inc said it is recalling four additional lots of its anti-smoking treatment, Chantix, after finding elevated levels of cancer-causing agents called nitrosamines in the pills. In June, the drugmaker…

Read More Here

Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd

Most people who received a third dose of Pfizer Inc's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial…

Read More Here

Tougher terms: why the EU is paying more for new COVID shots

The European Union has agreed to pay a premium on new orders of COVID-19 vaccines because it is requiring tougher terms to be met, European officials said, as the bloc tries to…

Read More Here

Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT

(Reuters) -Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price…

Read More Here

UPDATED: Israel to offer third shot of Pfizer vaccine to people over 60

Israel will begin offering a third shot of the Pfizer/Biontech COVID-19 vaccine to people aged over 60, a world first in efforts to slow the spread of the highly contagious…

Read More Here

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level – study

A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.…

Read More Here

Australia’s drug regulator approves Pfizer COVID-19 vaccine for 12 to 15-year-olds

Australia's drug regulator has approved Pfizer's COVID-19 vaccine for use with 12 to 15-year-olds, Federal Health Minister Greg Hunt said on Friday, as the country fights an outbreak of the…

Read More Here

Spacing Pfizer COVID shots boosts antibody levels after initial drop -study

A longer gap between doses of Pfizer's COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but there is a sharp…

Read More Here

Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds

Two doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study…

Read More Here

Israel offers third shot of Pfizer COVID-19 vaccine to adults at risk

Israel said on Sunday it will begin offering a third dose of Pfizer Inc's vaccine to adults with weak immune systems but it was still weighing whether to make the…

Read More Here

UPDATED: Pfizer to seek U.S. authorization for COVID booster shot as Delta variant spreads

Pfizer and partner BioNTech plan to ask U.S. and European regulators within weeks to authorize a booster dose of its COVID-19 vaccine, based on evidence of greater risk of infection…

Read More Here

Pfizer halts distribution of anti-smoking drug Chantix after finding carcinogen

Pfizer Inc said it is pausing distribution of its anti-smoking treatment, Chantix, after finding elevated levels of cancer-causing agents called nitrosamines in the pills. The drugmaker is recalling a number…

Read More Here

Pfizer and Moderna vaccines to include new warnings from FDA

The U.S. Food and Drug Administration said on Wednesday it plans to move quickly to add a warning about rare cases of heart inflammation in adolescents and young adults to…

Read More Here

Philippines seals deal for 40 mln Pfizer/BioNTech COVID-19 doses

The Philippine government has signed a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE in its biggest coronavirus vaccine deal to…

Read More Here

Heart inflammation in young men higher than expected after Pfizer, Moderna vaccines -U.S. CDC

A higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots from Pfizer/BioNTech and Moderna, according to data from two vaccine safety…

Read More Here

Pfizer to provide U.S. with 500 million COVID-19 vaccines to donate to world

Pfizer and German partner BioNTech said on Thursday they have agreed to supply the U.S. government with 500 million doses of their COVID-19 vaccine to donate to poorer countries over…

Read More Here

Pfizer to test COVID-19 vaccine in larger group of children below 12

Pfizer Inc said on Tuesday it will begin testing its COVID-19 vaccine in a bigger group of children under age 12 after selecting a lower dose of the shot in…

Read More Here

UPDATED: UK approves Pfizer/BioNTech COVID shot for 12- to 15-year-olds

Britain's medicines regulator said on Friday it had approved the COVID-19 vaccine developed by Pfizer and BioNTech for use on 12- to 15-year-olds, following similar clearances in the U.S. and…

Read More Here

Study suggests Pfizer jab recipients have lower antibodies targeting Indian variant

People who have received the Pfizer/BioNTech vaccine have fewer antibodies targeting the Indian COVID-19 variant compared to other strains, new data suggests. Levels of these antibodies are lower with increasing…

Read More Here

UPDATED: Israel sees probable link between Pfizer vaccine and heart inflammation cases

Israel's Health Ministry said on Tuesday it had found the small number of heart inflammation cases observed mainly in young men who received Pfizer's COVID-19 vaccine in Israel were likely…

Read More Here

Malta: 36,000 doses of Pfizer vaccine arrive in Malta

Deputy Prime Minister and Minister for Health Chris Fearne said that today 36,000 doses of the pfizer vaccine arrived in Malta. At a news conference, Dr Fearne explained that due…

Read More Here

Malta to vaccinate children between 12 and 15 years in July

Malta's Health Minister announced that children aged between 12 and 15 will start receiving the COVID-19 vaccine in July. The use of the Pfizer-BioNTech vaccine for teenagers between 12 and…

Read More Here

BioNTech says vaccine likely to be effective against India variant

BioNTech SE said the COVID-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to…

Read More Here

U.S. FDA says Pfizer COVID-19 vaccine can be stored in refrigerator for a month

The U.S. Food and Drug Administration authorized storage of Pfizer Inc and German partner BioNTech SE’s COVID-19 vaccine at standard freezer temperatures for up to one month, in an effort…

Read More Here

EU regulator backs month-long storage of Pfizer COVID-19 vaccine in fridges

Europe's drug regulator on Monday recommended extending the storage time for the Pfizer-BioNTech COVID-19 vaccine at normal fridge temperatures to 31 days from five days, easing logistical challenges during rollouts in the region.…

Read More Here

Delayed second Pfizer COVID-19 shot produces more antibodies -study

Pfizer's COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study said. The study…

Read More Here

Poland to shorten gap between COVID vaccine doses

Poland will shorten the gap between doses for Pfizer, Moderna and AstraZeneca COVID-19 jabs, the minister responsible for Poland's vaccination programme said on Monday. The gap between doses for the…

Read More Here

UPDATED: EU seals new Pfizer deal for 1.8 bln COVID-19 vaccines

The European Union signed a new contract with Pfizer-Biontech to receive 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cover booster shots, donations and reselling of doses, the European…

Read More Here

Pfizer asks Swiss OK for COVID-19 vaccine for children 12 to 15

ZURICH, May 7 (Reuters) - Pfizer has sought Swiss regulatory approval for its COVID-19 vaccine in children aged 12 to 15, regulator Swissmedic said on Friday. It is currently authorised…

Read More Here

Data from Israel shows 95% protection from infection after two doses of Pfizer jab

Two doses of Pfizer's COVID-19 vaccine can provide more than 95% protection against infection, severe illness, and death, according to the first nationwide data from Israel. A single dose of…

Read More Here

Canada becomes first country to allow Pfizer COVID-19 vaccine for children aged 12-15

OTTAWA, May 5 (Reuters) - Canada on Wednesday became the first nation in the world to authorize the use of Pfizer Inc's COVID-19 vaccine for children aged 12 to 15,…

Read More Here

Pfizer sees robust COVID-19 vaccine demand for years, $26 bln in 2021 sales

Pfizer Inc raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic…

Read More Here

South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shot

One dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older, real world data released by South Korea showed…

Read More Here

Risk from virus variants remains after first Pfizer COVID-19 vaccine, UK study finds

LONDON, April 30 (Reuters) - A single dose of Pfizer's coronavirus vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19,…

Read More Here

Pfizer begins exporting U.S.-made COVID-19 vaccine to Mexico

Pfizer Inc’s shipment of COVID-19 vaccine to Mexico this week includes doses made in its U.S. plant, the first of what are expected to be ongoing exports of its shots…

Read More Here

BioNTech and Pfizer expect vaccine tests on babies by end of Summer

BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months old, German magazine Spiegel cited the…

Read More Here

Israel examining heart inflammation cases in people who received Pfizer COVID shot

JERUSALEM, April 25 (Reuters) - Israel's Health Ministry said on Sunday it is examining a small number of cases of heartinflammation in people who had received Pfizer's COVID-19 vaccine, though it has not yet drawn any conclusions. Pfizer said it has not observed a…

Read More Here